Table: Taisho Pharmaceutical HD -6-MTH group results
Oct 30 (Reuters)-
Taisho Pharmaceutical Holdings Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2015 Sep 30, 2014 Mar 31, 2016
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 145.98 141.81 295.00
(+2.9 pct) (-1.9 pct) (+1.5 pct)
Operating 13.93 16.23 27.00
(-14.2 pct) (-24.5 pct) (-15.6 pct)
Recurring 17.68 19.59 35.00
(-9.7 pct) (-23.4 pct) (-11.6 pct)
Net 11.28 12.59 22.00
(-10.4 pct) (-23.8 pct) (-10.3 pct)
EPS 139.16 yen 155.34 yen 271.42 yen
EPS Diluted 139.09 yen 155.27 yen
Ann Div 110.00 yen 100.00 yen
-Q2 div 50.00 yen 50.00 yen
-Q4 div 60.00 yen 50.00 yen
NOTE - Taisho Pharmaceutical Holdings Co Ltd .
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on Taisho Pharmaceutical Holdings Co
See all newsBrief: Curi RMB Capital, Kaname Capital To Request Tokyo Court To Revise Taisho Pharmaceutical's Squeeze Out Price If Taisho Disagrees With Their Demand - Nikkei
Brief: Curi RMB Capital, Kaname Capital To Request Tokyo Court To Revise Taisho Pharmaceutical's Tender Offer Price If Taisho Disagrees Their Demand - Nikkei
Activist fund Oasis says it may take legal action over Taisho's management buyout
Brief: Curi RMB Capital Opposes Taisho Pharmaceutical HD's Management Buyout
To Retire Treasury Shares Worth 3.65% Of Outstanding Stock On April 10